首页> 外文期刊>Journal of Agricultural and Food Chemistry >Preparation and biological activity of four epiprogoitrin myrosinase-derived products.
【24h】

Preparation and biological activity of four epiprogoitrin myrosinase-derived products.

机译:四种表蛋白前体黑芥子酶衍生产品的制备和生物学活性。

获取原文
获取原文并翻译 | 示例
           

摘要

(5R)-5-Vinyl-1,3-oxazolidine-2-thione, (2S)-1-cyano-2-hydroxy-3-butene, and two diastereoisomeric erythro-(2S)- and threo-(2S)-1-cyano-2-hydroxy-3,4-epithiobutanes were prepared in pure form starting from (2S)-2-hydroxybut-3-enyl glucosinolate (epiprogoitrin). This glucosinolate was isolated in almost pure form using ripe seeds of Crambe abyssinica and then hydrolyzed under different conditions. The hydrolysis was carried out using either myrosinase immobilized on nylon, to produce (5R)-5-vinyl-1,3-oxazolidine-2-thione, or the endogenous myrosinase contained in defatted crambe meals, to produce the other epiprogoitrin-derived products. After purification and physicochemical characterization, all four myrosinase degradation products were tested for their biological activity. A bioassay on Lactuca sativa was chosen as a simple test to determine their apparent action on living tissues. (5R)-5-Vinyl-1,3-oxazolidine-2-thione negatively affected mainly root growth, whereas (2S)-1-cyano-2-hydroxy-3-butene affected the early phase of germination, and both (2S)-1-cyano-2-hydroxy-3,4-epithiobutane diastereoisomers appeared to negatively affect both germination and root growth at doses 5-10 times lower than those of (2S)-1-cyano-2-hydroxy-3-butene or (5R)-5-vinyl-1,3-oxazolidine-2-thione.
机译:(5R)-5-乙烯基-1,3-恶唑烷-2-硫酮,(2S)-1-氰基-2-羟基-3-丁烯和两个非对映异构的赤型-(2S)-和苏型-(2S)-从(2S)-2-羟基丁-3-烯基芥子油苷(表鬼臼酸甘油酯)开始以纯净形式制备1-氰基-2-羟基-3,4-表硫代丁烷。使用Crambe abyssinica的成熟种子将这种芥子油苷分离成几乎纯净的形式,然后在不同条件下进行水解。使用固定在尼龙上的黑芥子酶进行水解,以生产(5R)-5-乙烯基-1,3-恶唑烷-2-硫酮,或将脱脂蛤ram粉中所含的内源性黑芥子酶进行酶解,以生产其他表蛋白结合素。纯化和理化特性鉴定后,测试了所有四种黑芥子酶降解产物的生物活性。选择对莴苣的生物测定作为简单测试,以确定它们对活组织的明显作用。 (5R)-5-乙烯基-1,3-恶唑烷-2-硫酮主要负面影响根系生长,而(2S)-1-氰基-2-羟基-3-丁烯则影响发芽早期,且两者均影响(2S) )-1-氰基-2-羟基-3,4-表硫代丁烷非对映异构体似乎对发芽和根部生长均具有负面影响,其剂量比(2S)-1-氰基-2-羟基-3-丁烯低5-10倍或(5R)-5-乙烯基-1,3-恶唑烷-2-硫酮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号